Company Announcements

Bristol Myers Squibb to Present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Jan. 4, 2021-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference, which will be webcast on Monday, January 11, 2021. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.


Bristol Myers Squibb


Investor Relations:
Tim Power

Nina Goworek

Source: Bristol Myers Squibb